Zhonghua fu chan ke za zhi
-
Zhonghua Fu Chan Ke Za Zhi · Jan 2011
[Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
To analyze prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole. ⋯ For those patients who have to receive prophylactic chemotherapy because of risk factors and unavailable hCG assessments for follow-up, it's better to use double-agent or combination chemotherapy if the level of serum β-hCG reached 750 000 U/L so as to reduce therapy duration and prevent relevant chemoresistance.